| Primary |
| Product Used For Unknown Indication |
26.4% |
| Vertigo |
19.8% |
| Dry Skin |
9.9% |
| Prophylaxis |
6.6% |
| Pruritus |
6.6% |
| Psoriasis |
6.6% |
| Drug Use For Unknown Indication |
5.5% |
| Skin Ulcer |
4.4% |
| Rash Pruritic |
3.3% |
| Dermatitis Infected |
2.2% |
| Ligament Sprain |
2.2% |
| Skin Disorder |
2.2% |
| Eczema |
1.1% |
| Phimosis |
1.1% |
| Pruritus Genital |
1.1% |
| Swelling |
1.1% |
|
| Intentional Drug Misuse |
8.7% |
| Loss Of Consciousness |
8.7% |
| Rash Pustular |
8.7% |
| Ulcer |
8.7% |
| Birth Mark |
4.3% |
| Cataract |
4.3% |
| Congenital Genitourinary Abnormality |
4.3% |
| Constipation |
4.3% |
| Croup Infectious |
4.3% |
| Dermatitis Exfoliative |
4.3% |
| Drug Ineffective |
4.3% |
| Glaucoma |
4.3% |
| Insomnia |
4.3% |
| Pruritus |
4.3% |
| Pustular Psoriasis |
4.3% |
| Skin Atrophy |
4.3% |
| Skin Exfoliation |
4.3% |
| Swelling |
4.3% |
| Wound Secretion |
4.3% |
|
| Secondary |
| Product Used For Unknown Indication |
26.3% |
| Dry Skin |
13.2% |
| Vertigo |
10.5% |
| Dermatitis Atopic |
9.2% |
| Prophylaxis |
7.9% |
| Pruritus |
5.3% |
| Skin Ulcer |
5.3% |
| Itchy Rash |
3.9% |
| Ankle Sprain |
2.6% |
| Drug Use For Unknown Indication |
2.6% |
| Immunosuppression |
2.6% |
| Mycosis Fungoides |
2.6% |
| Bacterial Infection |
1.3% |
| Infection |
1.3% |
| Itching |
1.3% |
| Sexual Dysfunction |
1.3% |
| Sleep Disorder |
1.3% |
| Swelling |
1.3% |
|
| Congenital Genitourinary Abnormality |
14.3% |
| Loss Of Consciousness |
14.3% |
| Dermatitis Atopic |
7.1% |
| Drug Ineffective |
7.1% |
| Eczema |
7.1% |
| Insomnia |
7.1% |
| Rash Pruritic |
7.1% |
| Skin Exfoliation |
7.1% |
| Skin Hyperpigmentation |
7.1% |
| Therapeutic Response Unexpected |
7.1% |
| Wound Secretion |
7.1% |
| Xanthogranuloma |
7.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.7% |
| Psoriasis |
14.5% |
| Drug Use For Unknown Indication |
11.3% |
| Dermatitis Atopic |
5.2% |
| Hiv Infection |
4.1% |
| Eczema |
2.6% |
| Hypertension |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Hepatitis C |
2.0% |
| Pustular Psoriasis |
1.8% |
| Pruritus |
1.7% |
| Atrial Fibrillation |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Diabetes Mellitus |
1.2% |
| Malignant Melanoma |
1.2% |
| Rash |
1.2% |
| Depression |
1.0% |
| Non-hodgkin's Lymphoma |
1.0% |
| Dyspepsia |
0.9% |
| Pain |
0.9% |
|
| Rash |
11.9% |
| Anaemia |
7.1% |
| Psoriasis |
7.1% |
| Type 2 Diabetes Mellitus |
7.1% |
| Electrocardiogram Qt Prolonged |
6.0% |
| Lymphadenopathy |
6.0% |
| Atrial Fibrillation |
4.8% |
| Deafness |
4.8% |
| Malignant Melanoma |
4.8% |
| Toxic Epidermal Necrolysis |
4.8% |
| Chest Pain |
3.6% |
| Drug Eruption |
3.6% |
| Glomerulonephritis Membranous |
3.6% |
| Nausea |
3.6% |
| Red Blood Cell Sedimentation Rate Increased |
3.6% |
| Sepsis |
3.6% |
| Subcutaneous Abscess |
3.6% |
| T-cell Lymphoma |
3.6% |
| Therapy Non-responder |
3.6% |
| Vomiting |
3.6% |
|
| Interacting |
| Vertigo |
46.2% |
| Pruritus |
23.1% |
| Skin Ulcer |
23.1% |
| Sleep Disorder |
7.7% |
|
| Blood Cholesterol Increased |
33.3% |
| Constipation |
33.3% |
| Infection |
33.3% |
|
